Why Swiss Healthcare Models Are Attracting US Private Equity
Alastair Thorne · 10 min
European Medicines Agency Proposes New Data Sovereignty Rules
A draft regulation on clinical data residency could reshape cross-border trial economics.
By Elena Drumm•8 min read•
What's on the table
New obligations around where patient-level trial data may be processed.
Industry reaction
CROs with pan-European operations are among the most affected.
Share
Related coverage
The Vanadium Brief
Every Monday morning, the definitive analysis of healthcare markets in your inbox.